arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cellectis S.A.

CLLS Health Care Biotechnology: Pharmaceutical Preparations
$0.98
▲ +1.1% Today
as of Oct 23, 16:47 ET
Last 30 days -46.45% Sep 14 → Oct 23
$0.85 $1.12 $1.38 $1.64 $1.90 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.00
High
$1.02
Low
$0.96
Volume
$13,648
Avg Vol
$68,285
Mkt Cap
$135M
P/E (TTM)
—
Beta
—
52w High
$5.45
52w Low
$0.88
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 10 items

Oct 1 · 20:02 MarketBeat
Cellectis Unveils In Vivo Gene-Editing Plans for Severe Lipid Disorders
Sep 17 · 05:16 Insider Monkey
Cellectis (CLLS) Exits Two CAR-T Programs. Can Gene Editing Justify the Clinical Reset?
Sep 16 · 10:37 MT Newswires
Barclays Downgrades Cellectis to Underweight From Overweight, Adjusts PT to $1.30 From $9
▸ Show all 10 press releases & news Free account →

CLLS earnings at a glance

Cellectis S.A. (CLLS) is scheduled to report earnings on Friday, November 6, 2026 — in 14 days. The options market is pricing a move of about ±10.1% after the report, a range of roughly $0.88 to $1.08 from today's $0.98. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.9% on average; after the most recent report on May 11, 2026 it moved +3.4%. That means options currently expect more movement than CLLS has typically delivered. Implied volatility is currently 50%. The share price of $0.98 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.88
$5.45
2% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-0.5%
50% positive
Latest IV / EM
50%
EM ±10.1% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.24$-0.18$-0.11$-0.05$0.01 Actual $-0.18Actual $-0.24Actual $0.01Actual $-0.18 Mar/2025Jun/2025Sep/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.18 — — 0.0% +3.4% earnings
Fri Nov 7, 2025Sep/2025 $0.01 — — — — earnings
Mon Aug 4, 2025Jun/2025 $-0.24 — — — — earnings
Mon May 12, 2025Mar/2025 $-0.18 — — — -4.4% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Fri Nov 6, 2026Sep/2026OTHER —$0.01

Implied volatility — last 90 days

47%814%1581%2348%3116% Jun 08 — IV 762% · EM ±100.7%Jun 09 — IV 814% · EM ±102.0%Jun 10 — IV 839% · EM ±99.1%Jun 11 — IV 937% · EM ±103.6%Jul 09 — IV 1364% · EM ±161.1%Jul 10 — IV 1455% · EM ±160.7%Jul 13 — IV 82% · EM ±6.8%Jul 14 — IV 100% · EM ±7.2%Jul 22 — IV 468% · EM ±107.1%Jul 23 — IV 476% · EM ±107.1%Aug 04 — IV 726% · EM ±125.0%Aug 05 — IV 727% · EM ±121.4%Sep 15 — IV 1631% · EM ±118.0%Sep 16 — IV 2838% · EM ±167.6%Sep 17 — IV 3116% · EM ±130.1%Sep 22 — IV 47% · EM ±9.6%Sep 23 — IV 50% · EM ±10.1%

Sector peers

PMVP
PMV Pharmaceuticals, Inc.
$132M $1.27-6.6%
SPRB
Spruce Biosciences, Inc.
$129M $45.15+5.7%
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$123M $4.05-5.5%
ASRT
Assertio Holdings, Inc.
$151M $23.50
PEPG
PepGen Inc.
$153M $2.52-7.3%
AARD
Aardvark Therapeutics, Inc.
$115M $1.39-68.5%

CLLS earnings FAQ

When is CLLS's next earnings date?

Cellectis S.A. is expected to report on November 6, 2026.

What is CLLS's expected move for earnings?

Options currently price a move of about ±10.1%, or $0.10 per share either way from $0.98.

How does CLLS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.9%, up 1 times and down 1 times.

What is CLLS's implied volatility?

CLLS's at-the-money implied volatility is about 50% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in